isoprene has been researched along with Crush Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Haruta, Y; Hata, K; Iida, K; Iura, H; Kawaguchi, K; Kijima, K; Kitade, K; Kobayakawa, K; Konno, DJ; Kubota, K; Maeda, T; Matsumoto, Y; Nakashima, Y; Okada, S; Ono, G; Saiwai, H; Tamaru, T | 1 |
1 other study(ies) available for isoprene and Crush Syndrome
Article | Year |
---|---|
Zinc chelator treatment in crush syndrome model mice attenuates ischemia-reperfusion-induced muscle injury due to suppressing of neutrophil infiltration.
Topics: Animals; Anti-Inflammatory Agents; Chelating Agents; Chemokines; Crush Syndrome; Cytokines; Ethylenediamines; Inflammation; Interleukin-6; Ischemia; Mice; Muscles; Neutrophil Infiltration; Reperfusion; Reperfusion Injury; Rubber; Tumor Necrosis Factor-alpha; Zinc | 2022 |